MedPage Today on MSN
Overcoming CDK4/6 Inhibitor Resistance in HR-Positive/HER2-Negative Breast Cancer
In the CAPItello-291 trial of capivasertib plus fulvestrant, 73% of patients had already received a CDK4/6 inhibitor. As ...
DECLARATION is a Phase 3, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of VYD2311 in the prevention of COVID ...
The UK government has published a new homelessness strategy for England. The strategy speaks to different forms of ...
18hon MSN
The UK wants to scrap jury trials for many crimes. Opponents fear the loss of an ancient right
For hundreds of years, Britons accused of substantial crimes have had the right to be tried by their peers in a court of law.
Echoing a longstanding anti-vaccine trope, President Donald Trump falsely claimed that the American vaccine schedule "long ...
Study Finds on MSN
Menopause hormone therapy and brain health: What research on 1 million women tells us
A tenuous connection between hormone therapy and increased dementia risk was noted, but more research is warranted. In A ...
Liquid Drop Formula Features Grape Seed Extract, Green Tea, GABA and Antioxidant Botanicals Targeting Inner Ear Health and ...
The Walrus on MSN
Ukraine’s War Is Producing a New Politics of Memory
We think of our private lives as sealed off from the public world, but war reveals the provisional nature of those walls, and ...
While not all sections of the experience hit upper-echelon theming as the first and final areas, Escape The Dark is a unique ...
In 2025, cardiology delved deeper into sex-specific risk factors and how to leverage them in prevention, Stacey Rosen says.
This study provides important evidence that negative affect is associated with slower cognitive processing in daily life, with findings replicated across three independent samples and supported by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results